Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastrointest Endosc. Sep 25, 2015; 7(13): 1096-1102
Published online Sep 25, 2015. doi: 10.4253/wjge.v7.i13.1096
Table 1 International Classification of Disease, ninth revision procedure and diagnosis codes used to determine surgical procedure categories and complications
ICD-9 code
Achalasia530
Heller1427
Esophagectomy142.4, 42.41, 42.42, 42.5, 42.51-59, 42.6, 42.61-69
Esophageal cancer150, 150.1, 150.2, 150.3, 150.4, 150.5, 150.8, 151
Complications
Pneumonia481, 482.0-482.4, 482.8-482.9, 483, 484, 485, 486, 507.0, 482.40, 482.41. 482.42, 482.49
Urinary tract infection997.5, 599.0-599.9
Shock/sepsis998.0, 995.9, 995.90, 995.91, 995.92, 038
Pulmonary compromise514, 518.4, 518.5, 518.81, 518.82
Table 2 Baseline demographic and clinical characteristics of patients among the three groups, Nationwide Inpatient Sample, 2003-2010 n (%)
TotalGroup 1Group 2Group 3P
31769Heller 5567 (49.00)Esophagectomy 785 (2.47)Non-surgical 15417 (48.53)
Age, mean (median)59 (59)51.2 (51)53.8 (54)67.1 (72)< 0.001
Age category< 0.001
18-448041 (25.31)5576 (35.82)251(31.97)2214 (14.36)
45-6410554 (33.22)6330 (40.66)308 (39.24)3916 (25.40)
65-744746 (14.94)2254 (14.48)141 (17.96)2351 (15.25)
≥ 758428 (26.53)1407 (9.04)85 (10.83)6936 (44.99)
Gender1< 0.001
Male14429 (45.73)7883 (51.21)371 (47.41)6175 (40.17)
Female17120 (54.27)7510 (48.79)412 (52.59)9198 (59.83)
Race20.002
White17663 (70.77)8662 (71.64)403 (65.96)8598 (70.15)
Black3662 (14.67)1533 (12.68)75 (12.27)2054 (16.76)
Other3633 (14.56)1896 (15.68)133 (21.77)1604 (13.09)
Charlson score0.630.340.480.930.036
021147 (64.53)11681 (75.04)508 (64.71)7958 (51.62)< 0.001
17390 (22.55)3015 (19.37)206 (26.24)4169 (27.04)
≥ 24232 (12.91)871 (5.59)71 (9.05)3290 (21.34)
Table 3 Most common procedure types for patients who underwent non-surgical treatment of achalasia
ICD-9 codeProcedure typeGroup 3
Non-surgical 15417
45.13 and 45.16Esophagogastroduodenoscopy65.15%
42.92Dilation of esophagus26.94%
99.57 and 99.29Injection of therapeutic/prophylactic substance-including botulism antitoxin17.32%
98.02Removal of intraluminal foreign body from esophagus without incision6.44%
43.11Percutaneous endoscopic gastrostomy percutaneous transabdominal gastrostomy5.73%
29.31Cricopharyngeal myotomy2.77%
Table 4 Observed unadjusted rates of outcomes across the three patient groups, Nationwide Inpatient Sample, 2003-2010 n (%)
TotalGroup 1Group 2Group 3P
31769Heller 15567 (49.00)Esophagectomy 785 (2.47)Non-surgical 15417 (48.53)
In-hospital mortality206 (0.65)16 (0.1)15 (1.96)180 (1.17)< 0.001
Disposition
Home127916 (87.87)15130 (97.19)637 (81.15)12149 (78.80)< 0.001
Transfer23504 (11.03)416 (2.67)133 (16.89)2955 (19.17)< 0.001
Pneumonia1959 (6.17)509 (3.27)150 (19.11)1300 (8.43)< 0.001
UTI1462 (4.60)311 (2.00)50 (6.37)1101 (7.14)< 0.001
Shock/sepsis171 (0.54)50 (0.32)46 (5.86)75 (0.49)< 0.001
Pulmonary compromise813 (2.56)241 (1.55)245 (31.21)327 (2.12)< 0.001
Median LOS (d)32134< 0.001
Median TOTCHG$26299.41$30118.12$134670.40$21175.23< 0.001
Table 5 Adjusted odds ratios of outcomes and complications for the non-surgical group (in comparison to the Heller group)
ORP95%CI
In-hospital mortality4.730.031.16-19.31
Disposition
Home0.24< 0.0010.19-0.31
Transfer3.76< 0.0012.85-4.97
Pneumonia1.91< 0.0011.42-2.58
Urinary tract infection2.31< 0.0011.67-3.18
Shock/sepsis1.180.7260.47-2.97
Pulmonary compromise0.830.4130.54-1.29
Table 6 Adjusted odds ratios of outcomes and complications for the esophagectomy group (in comparison to the non-surgical group)
ORP95%CI
In-hospital mortality7.280.0022.06-25.79
Disposition
Home0.540.0090.35-0.86
Transfer1.840.0101.16-2.94
Pneumonia3.68< 0.0012.40-5.64
Urinary tract infection1.280.5070.62-2.67
Shock/sepsis16.530.0016.36-42.96
Pulmonary compromise37.97< 0.00122.85-63.07